Clin. Chim. Acta 2020 Jan 28
Advances in prostate specific antigen biosensors-Impact of nanotechnology.
Negahdary M, Sattarahmady N, Heli H
Prostate cancer is one of the most dangerous and deadly cancers in elderly men. Early diagnosis using prostate-specific antigen (PSA) facilitates dise ...
Read More
Source: PubMed
Urologiia
[Conservative management of rectourethral fistula: modern treatment].
Popov SV, Orlov IN, Gadjiev NK, Obidnyak VM, Sytnik DA, Kulikov AY, Akopyan GN, Gadzhieva ZK, Spiridonov NY
& Objectives. Rectal injury and recto-urethral fistula (RUF) formation are severe complications after surgical treatment of prostate cancer . There ar ...
Read More
Source: PubMed
Eur. Urol. 2020 Jan 27
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A
Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspect ...
Read More
Source: PubMed
Ann. Oncol.
Novel treatment options in the management of metastatic castration-naïve prostate cancer; which treatment modality to choose?
Belderbos BPS, de Wit R, Lolkema MPJ, Mathijssen RHJ, van Soest RJ
Androgen-deprivation therapy (ADT) has been the mainstay of treatment of metastatic prostate cancer since the first report of its hormonal dependence ...
Read More
Source: PubMed
Ann. Oncol.
Advances in targeted alpha therapy for prostate cancer.
De Vincentis G, Gerritsen W, Gschwend JE, Hacker M, Lewington V, O'Sullivan JM, Oya M, Pacilio M, Parker C, Shore N, Sartor O
Amongst therapeutic radiopharmaceuticals, targeted alpha therapy (TaT) can deliver potent and local radiation selectively to cancer cells as well as t ...
Read More
Source: PubMed
